- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Rapid On-Site Microscopy and Mapping of Diagnostic Biopsies for See-And-Treat Guidance of Localized Prostate Cancer Therapy.
February 22, 2023
Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
February 22, 2023
Utilizing clinical, pathological and radiological information to guide post-operative radiotherapy in prostate cancer.
February 21, 2023
Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review.
February 21, 2023
DNA repair deficiency as circulating biomarker in prostate cancer.
February 21, 2023
Racial differences in prostate tumor microenvironment: implications for disparate clinical outcomes and potential opportunities.
February 21, 2023
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
February 20, 2023
Safety differences across androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancer.
February 20, 2023
Preclinical models of prostate cancer - modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo.
February 17, 2023
Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system.
February 17, 2023
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment.
February 17, 2023
Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models.
February 17, 2023